Emraclidine was expected to be a blockbuster drug for AbbVie, and this development didn’t sit well with investors.

CHICAGO – Illinois will receive a $40 million share of a $1.4 billion bipartisan national settlement with Kroger over the ...

Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced that the sixth annual BOTOX® Cosmetic Day will be Wednesday, ...

Last year, the department announced opioid settlements of nearly $219.4 million, to be received over 15 years, from Teva, ...

A Baltimore jury found two drug distributors liable for contributing to the city's ongoing opioid crisis. The decision came ...

The beauty pioneer continues to serve as the gold standard in aesthetics in the Philippines Last Oct. 16 at Shangri-La The ...

He was founder, president, chief executive and member of the board of directors of Sienna Biopharmaceuticals and took the company public in 2017, and previously served as Chief Medical Officer at ...

Discover how AbbVie investors that bought the anxiety over the loss of Humira exclusivity are sitting on massive gains. Read ...

The Society’s awards recognize the dermatologic surgeons who have gone above and beyond for the organization and participated ...

Pfizer and Allergan have confirmed that they will merge in a $160 billion deal, with Ireland-domiciled Allergan acquiring the US pharma giant, and re-naming itself Pfizer. The deal is the biggest ...

Kikuchi–Fujimoto disease (KFD), histiocytic necrotising lymphadenitis, is a benign and self-limiting disease characterised ...